BMC Public Health

official impact factor 2.36

Open Access Highly Access Pre-publication history

Adverse effects of the antimalaria drug, mefloquine: due to primary liver damage with secondary thyroid involvement?

Ashley M Croft* and Andrew Herxheimer

BMC Public Health 2002, 2:6 doi:10.1186/1471-2458-2-6

Pre-publication versions of this article and reviewers' reports

Original Submission - Version 1 Manuscript 17 Dec 2001
Reviewer's Report R Price 21 Feb 2002
Resubmission - Version 3 Manuscript Author's comment 15 Mar 2002
Reviewer's Report R Price 25 Mar 2002
Published 25 Mar 2002